AI in Health Care: Foundations, Myths, and Practical Applications
Featuring Ira Klein, MD, MBA 02/07/2024 Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it...
Category: Interviews
Executive Roundtable: The Rise of RWD in Clinical Research
Earlier this year, a panel consisting of leaders from the clinical research industry convened for a virtual roundtable to discuss the emerging uses of real-world data (RWD) drug development. The...
Memo to tech companies: Hospitals are looking for ROI, ASAP
Mar 31, 2023 Ron Southwick Health leaders say they’re open to work with companies on digital health initiatives. But with a difficult financial landscape, they can’t wait long to get...
How synthetic data can boost efficiency for clinical researchers and IT leaders
Washington University and Ottawa Hospital used synthetic data to review a sepsis prediction model used in both institutions over the course of two phone calls – and avoided months of conventional...
Exchanging data, improving care: Interoperability gains momentum
February 16, 2023 Ron Southwick Health Gorilla’s Steven Lane talks about the growing support for sharing information, the obstacles ahead, and why interoperability can lead to greater health equity. As...
Duke Health Joins with nference to Advance Medical Research and Patient Care
January 04, 2023 08:40 AM Eastern Standard Time DURHAM, N.C.–(BUSINESS WIRE)–Duke Health is building upon its longstanding history of innovative research by joining with nference, a science-first software company, to...
Medcity Pivot Podcast: A Conversation With COTA CEO Miruna Sasu About RWE
Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However,...
Bertagnolli sets out eight “core principles” for NCI: “We’ve got to be nimbler, faster”
It’s time to supercharge NCI’s role in redefining clinical trials and in strengthening the cancer research enterprise, NCI Director Monica Bertagnolli said Nov. 9 in her first director’s report. “I have...
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was...
What is Real-World Evidence and How Does It Help Patients?
A Q&A with Josh Gagne, Vice President and Global Head of Epidemiology, Johnson & Johnson Innovative new medicines and medical technologies undergo robust safety assessments before they are made available...